Inspired by medical innovations. Driven by passion.
Eyerising Myopia Management Device

Eyerising Myopia Management Device by Eyerising International, is the world first at-home red-light therapy device aimed to slow the progression of childhood myopia. Repeated low-level red-light (RLRL) therapy has been used in the treatment of various medical conditions for almost half century. It’s now been shown that controlled exposure to low-level single wavelength red-light can prevent or slow down the progression of myopia.

Features and Benefits:

  • Non-invasive
  • No drugs
  • No injections
  • No specialised lenses and no risk of infection
  • No significant side effects
  • Suitable and easily tolerated by children as young as 3 years.
  • Comprehensive patient compliance data provided to clinicians for use in patient examinations

Safety and Efficacy proven in multi-centre randomized clinical trials, and published in prestigious scientific magazines.

Eyerising Myopia Management Device has been cleared as a medical device by the following regulators: CFDA (China), CE (EU), TGA (Australia), Medsafe (NZ) and MHRA (UK) and is ISO 13485 certified.

Eye-Lens Shape Eye-Lens Shape Eye-Lens Shape

The Best in Medical Technologies

Eye-Lens Pte Ltd is a technology transfer and distribution company in the field of Medical Devices and Pharmaceuticals. We specialize in identifying innovative products in the Medical Domain, transferring, distributing and marketing them in Asia, with an emphasis on the Japan and Singapore markets. Eye-Lens services and maintains the products we provide at the highest level. We have service centres in both our Singapore and Japan offices. Our dedicated team of qualified engineers and technicians always endeavour to provide our customers with prompt and efficient response to their service needs.